Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels.

Pu Y, Xue J, Wang W, Xu B, Gu Y, Tang R, Ackerstaff E, Koutcher JA, Achilefu S, Alfano RR. Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels. J Biomed Opt. 2013 Aug; 18(8):87002.

View in: PubMed

authors with profiles

Robert R. Alfano

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support